Analysis of factors leading to early termination in glioblastoma-related clinical trials

[1]  D. Mandel,et al.  Principal investigators over-optimistically forecast scientific and operational outcomes for clinical trials , 2022, PloS one.

[2]  V. Bogin.  Lasagna's law: A dish best served early , 2022, Contemporary clinical trials communications.

[3]  Susan M. Chang,et al.  Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement. , 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  H. Cohen,et al.  Older adult participation in cancer clinical trials: A systematic review of barriers and interventions , 2020, CA: a cancer journal for clinicians.

[5]  Susan M. Chang,et al.  Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients. , 2020, Neuro-oncology.

[6]  Atique U. Ahmed,et al.  Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations. , 2019, Clinical breast cancer.

[7]  Susan M. Chang,et al.  Barriers to Accrual and Enrollment in Brain Tumor Trials. , 2019, Neuro-oncology.

[8]  Mark D. Anderson,et al.  Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center. , 2019, European journal of cancer.

[9]  Lorenzo Trippa,et al.  The clinical trials landscape for glioblastoma: is it adequate to develop new treatments? , 2018, Neuro-oncology.

[10]  W. Yung,et al.  HOUT-15. BRAIN TUMOR PATIENT AND CAREGIVER SURVEY ON CLINICAL TRIALS: IDENTIFYING ATTITUDES AND BARRIERS TO PATIENT PARTICIPATION , 2017 .

[11]  Tony Tse,et al.  Terminated Trials in the ClinicalTrials.gov Results Database: Evaluation of Availability of Primary Outcome Data and Reasons for Termination , 2015, PloS one.

[12]  Tim Ramsay,et al.  Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials , 2015, Clinical trials.

[13]  R. Califf,et al.  Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: insights from the ClinicalTrials.gov registry. , 2014, American heart journal.

[14]  Jill S. Barnholtz-Sloan,et al.  Epidemiologic and Molecular Prognostic Review of Glioblastoma , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[15]  Harold L. Moses,et al.  A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program , 2010 .

[16]  Harlan M Krumholz,et al.  Participation in cancer clinical trials: race-, sex-, and age-based disparities. , 2004, JAMA.

[17]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013. , 2016, Neuro-oncology.